Studies at the London Migraine Institute have increased interest in the parthenolide in Feverfew for its role in maintaining normal blood vessel tone. Feverfew helps maintain normal blood vessel bone by reducing platelet aggregation, serotonin release from platelets and blocking the formation of pro-inflammatory mediators. New improves Mygrafew provides the level of parthenolide recommended by both Canadian and British health authorities for optimal results. Each tablet provides the recommended level of 600 mcg parthenolide in a once daily dosage. New high potency Mygrafew is standardized to 5% parthenolide - 7X more potent than other feverfew extracts. Mygrafew is the only feverfew extract with guaranteed parthenolide stability for three years. Mygrafew is free of common food allergens such as yeast, milk, lactose, wheat, sugar, soy or corn
